Literature DB >> 21596839

Reproductive dysfunction and decreased GnRH neurogenesis in a mouse model of CHARGE syndrome.

Wanda S Layman1, Elizabeth A Hurd, Donna M Martin.   

Abstract

CHARGE is a multiple congenital anomaly disorder and a common cause of pubertal defects, olfactory dysfunction, growth delays, deaf-blindness, balance disorders and congenital heart malformations. Mutations in CHD7, the gene encoding chromodomain helicase DNA binding protein 7, are present in 60-80% of individuals with the CHARGE syndrome. Mutations in CHD7 have also been reported in the Kallmann syndrome (olfactory dysfunction, delayed puberty and hypogonadotropic hypogonadism). CHD7 is a positive regulator of neural stem cell proliferation and olfactory sensory neuron formation in the olfactory epithelium, suggesting that the loss of CHD7 might also disrupt development of other neural populations. Here we report that female Chd7(Gt/+) mice have delays in vaginal opening and estrus onset, and erratic estrus cycles. Chd7(Gt/+) mice also have decreased circulating levels of luteinizing hormone and follicle-stimulating hormone but apparently normal responsiveness to gonadotropin-releasing hormone (GnRH) agonist and antagonist treatment. GnRH neurons in the adult Chd7(Gt/+) hypothalamus and embryonic nasal region are diminished, and there is decreased cellular proliferation in the embryonic olfactory placode. Expression levels of GnRH1 and Otx2 in the hypothalamus and GnRHR in the pituitary are significantly reduced in adult Chd7(Gt/+) mice. Additionally, Chd7 mutant embryos have CHD7 dosage-dependent reductions in expression levels of Fgfr1, Bmp4 and Otx2 in the olfactory placode. Together, these data suggest that CHD7 has critical roles in the development and maintenance of GnRH neurons for regulating puberty and reproduction.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21596839      PMCID: PMC3140819          DOI: 10.1093/hmg/ddr216

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  108 in total

1.  The Otx2 homeoprotein regulates expression from the gonadotropin-releasing hormone proximal promoter.

Authors:  C G Kelley; G Lavorgna; M E Clark; E Boncinelli; P L Mellon
Journal:  Mol Endocrinol       Date:  2000-08

2.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

Review 3.  Cooperation between complexes that regulate chromatin structure and transcription.

Authors:  Geeta J Narlikar; Hua-Ying Fan; Robert E Kingston
Journal:  Cell       Date:  2002-02-22       Impact factor: 41.582

Review 4.  ATP-dependent nucleosome remodeling.

Authors:  Peter B Becker; Wolfram Hörz
Journal:  Annu Rev Biochem       Date:  2001-11-09       Impact factor: 23.643

5.  Role of brain insulin receptor in control of body weight and reproduction.

Authors:  J C Brüning; D Gautam; D J Burks; J Gillette; M Schubert; P C Orban; R Klein; W Krone; D Müller-Wieland; C R Kahn
Journal:  Science       Date:  2000-09-22       Impact factor: 47.728

6.  Basic fibroblast growth factor and fibroblast growth factor receptors in adult olfactory epithelium.

Authors:  P Hsu; F Yu; F Féron; J O Pickles; K Sneesby; A Mackay-Sim
Journal:  Brain Res       Date:  2001-03-30       Impact factor: 3.252

Review 7.  Mutations of follicle stimulating hormone-beta and its receptor in human and mouse: genotype/phenotype.

Authors:  L C Layman; P G McDonough
Journal:  Mol Cell Endocrinol       Date:  2000-03-30       Impact factor: 4.102

8.  Pax6 regulates craniofacial form through its control of an essential cephalic ectodermal patterning center.

Authors:  Claudia Compagnucci; Jennifer L Fish; Manuela Schwark; Victor Tarabykin; Michael J Depew
Journal:  Genesis       Date:  2011-04       Impact factor: 2.487

9.  FGF signaling through FGFR1 is required for olfactory bulb morphogenesis.

Authors:  Jean M Hébert; Mary Lin; Juha Partanen; Janet Rossant; Susan K McConnell
Journal:  Development       Date:  2003-03       Impact factor: 6.868

10.  Opposing effects of bone morphogenetic proteins on neuron production and survival in the olfactory receptor neuron lineage.

Authors:  J Shou; R C Murray; P C Rim; A L Calof
Journal:  Development       Date:  2000-12       Impact factor: 6.868

View more
  30 in total

1.  CHD7 and retinoic acid signaling cooperate to regulate neural stem cell and inner ear development in mouse models of CHARGE syndrome.

Authors:  Joseph A Micucci; Wanda S Layman; Elizabeth A Hurd; Ethan D Sperry; Sophia F Frank; Mark A Durham; Donald L Swiderski; Jennifer M Skidmore; Peter C Scacheri; Yehoash Raphael; Donna M Martin
Journal:  Hum Mol Genet       Date:  2013-09-10       Impact factor: 6.150

2.  Dysregulation of cotranscriptional alternative splicing underlies CHARGE syndrome.

Authors:  Catherine Bélanger; Félix-Antoine Bérubé-Simard; Elizabeth Leduc; Guillaume Bernas; Philippe M Campeau; Seema R Lalani; Donna M Martin; Stephanie Bielas; Amanda Moccia; Anshika Srivastava; David W Silversides; Nicolas Pilon
Journal:  Proc Natl Acad Sci U S A       Date:  2018-01-08       Impact factor: 11.205

Review 3.  Inner ear manifestations in CHARGE: Abnormalities, treatments, animal models, and progress toward treatments in auditory and vestibular structures.

Authors:  Daniel I Choo; Kareem O Tawfik; Donna M Martin; Yehoash Raphael
Journal:  Am J Med Genet C Semin Med Genet       Date:  2017-10-30       Impact factor: 3.908

Review 4.  Chromodomain helicase DNA-binding proteins in stem cells and human developmental diseases.

Authors:  Joseph A Micucci; Ethan D Sperry; Donna M Martin
Journal:  Stem Cells Dev       Date:  2015-02-25       Impact factor: 3.272

5.  MicroRNA-382 expression is elevated in the olfactory neuroepithelium of schizophrenia patients.

Authors:  Eyal Mor; Shin-Ichi Kano; Carlo Colantuoni; Akira Sawa; Ruth Navon; Noam Shomron
Journal:  Neurobiol Dis       Date:  2013-03-29       Impact factor: 5.996

Review 6.  The Chromodomain Helicase DNA-Binding Chromatin Remodelers: Family Traits that Protect from and Promote Cancer.

Authors:  Alea A Mills
Journal:  Cold Spring Harb Perspect Med       Date:  2017-04-03       Impact factor: 6.915

Review 7.  CHARGE syndrome: a review of the immunological aspects.

Authors:  Monica T Y Wong; Elisabeth H Schölvinck; Annechien J A Lambeck; Conny M A van Ravenswaaij-Arts
Journal:  Eur J Hum Genet       Date:  2015-02-18       Impact factor: 4.246

8.  More Clinical Overlap between 22q11.2 Deletion Syndrome and CHARGE Syndrome than Often Anticipated.

Authors:  N Corsten-Janssen; S C Saitta; L H Hoefsloot; D M McDonald-McGinn; D A Driscoll; R Derks; K A Dickinson; W S Kerstjens-Frederikse; B S Emanuel; E H Zackai; C M A van Ravenswaaij-Arts
Journal:  Mol Syndromol       Date:  2013-05-28

Review 9.  Genetics of Combined Pituitary Hormone Deficiency: Roadmap into the Genome Era.

Authors:  Qing Fang; Akima S George; Michelle L Brinkmeier; Amanda H Mortensen; Peter Gergics; Leonard Y M Cheung; Alexandre Z Daly; Adnan Ajmal; María Ines Pérez Millán; A Bilge Ozel; Jacob O Kitzman; Ryan E Mills; Jun Z Li; Sally A Camper
Journal:  Endocr Rev       Date:  2016-11-09       Impact factor: 19.871

10.  Responsiveness to a physiological regimen of GnRH therapy and relation to genotype in women with isolated hypogonadotropic hypogonadism.

Authors:  Brent S Abel; Natalie D Shaw; Jenifer M Brown; Judith M Adams; Teresa Alati; Kathryn A Martin; Nelly Pitteloud; Stephanie B Seminara; Lacey Plummer; Duarte Pignatelli; William F Crowley; Corrine K Welt; Janet E Hall
Journal:  J Clin Endocrinol Metab       Date:  2013-01-22       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.